The University at Buffalo (UB) is looking for volunteers to join a long COVID-19 registry. Our goal is to build a registry of local Western New York community members who are experiencing the effects of long COVID-19 infection. This registry will help us to share news about long COVID-19 as we learn more about this condition. UB researchers will also use the registry to communicate information about studies recruiting volunteers with long COVID-19. Read More
Adults over the age of 18 years old
Experiencing symptoms of long COVID-19 infection
Live in one of the eight counties of Western New York (Niagara, Erie, Chautauqua, Cattaraugus, Allegany, Wyoming, Genesee, and Orleans)
Study to evaluate reducing worry, anxiety, and stress in underserved communities highly impacted by the COVID-19 pandemic. Mindfulness Based Stress Reduction programs (meditation, breathing and movement) will be delivered via video / teleconference or a smart phone APP. The study lasts approximately 21 weeks. Read More
(1) age 18 years and older
(2) a baseline score ≥26 (clinically significant worry) on the Penn State Worry Questionnaire-Abbreviated
(3) fluency in English
(4) reside in one of the underserved, census-identified primarily African American communities in Buffalo, NY
(5) severe depression
(6) active suicidal intent
(7) DSM-V diagno...
This study enrolls healthy adults who will be getting a vaccine. The goal of this study is to learn about immune system cells called macrophages. Macrophages are important immune system cells that form when an infection is in the body. Read More
Adults ages 20-55.
Scheduled to receive a vaccine, like the COVID-19 or flu vaccine (for COVID-19 vaccine, study must be done before and after the first dose of the vaccine).
This study enrolls children and adults who have tested positive for COVID-19. The purpose of this study is to collect and bank blood samples of people who have COVID-19. We will analyze these samples to understand more about the virus. Read More
Adults or children
Positive for SARS-CoV-2 or highly suspicious for SARS-CoV-2 (symptoms with known contact).